Achieving Ultrafast Liquid Chromatography - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Achieving Ultrafast Liquid Chromatography
The authors review methods for reducing analysis time and increasing throughput that are reliable and maintain data integrity.


Pharmaceutical Technology


Many applications, however, can be accomplished with a single, well-engineered, component-based HPLC system. To limit oneself to a highly restrictive system in today's ever-changing laboratory environment is not ideal. One may need to add different detectors to the system to accomplish a new task or one may add switching valves to increase throughput even more. A modular system that is based on sound engineering principles includes pumping options that deliver a wide flow-rate range with precise delivery resolution, incorporates an accurate and precise autosampler that provides excellent carryover performance, and has the accessories necessary for continued expansion offers superior performance for UFLC and traditional HPLC.

Conclusion

One can address the problem of increased system pressure that results from very small particle-size columns by choosing a well-packed mid-size particle material instead. These mid-size columns offer similar performance, yet generate less than half of the back pressure compared with commercially available sub-2-μm particle columns. Coupling these mid-size particle columns with good chromatographic techniques and a well-engineered high-performance liquid chromatography system enables users to shorten analysis time drastically, without the consequence of extreme pressures. The right columns and techniques also permit users to maintain high separation efficiency and fulfill system-performance needs such as reproducibility, reduced carryover, and durability. The end result is high-quality data obtained without compromises.

The goal of fast liquid chromatography is not high pressure; high pressure is simply a consequence of using a column packed with a small particle (sub 2 μm). The goal is increased throughput (i.e., analyzing more samples per day, per hour or per minute). To achieve high throughput, the run time of a single chromatogram must be optimized, and the total cycle time of the assay must be examined and optimized as well. After all, what good is a 30-s separation if it takes 45 s to inject the next sample?

Curtis R. Campbell, PhD*, is a high-performance liquid chromatography (HPLC) product manager, and Susan Steinike is an HPLC senior product specialist at Shimadzu Scientific Instruments, 7102 Riverwood Dr., Columbia, MD 21046, tel. 800.477.1227,

*To whom all correspondence should be addressed.

Reference

1. Butchart, et al., "Do Sub 2 μm Particles Offer the Best Performance for Short Fast Gradients?" in poster session presented at the 31st International Symposium on High Performance Liquid Phase Separations and Related Techniques (Ghent, Belgium, June 17–21, 2007)


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here